{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:19:24Z","timestamp":1775251164040,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.optm.2006.05.001","type":"journal-article","created":{"date-parts":[[2006,9,25]],"date-time":"2006-09-25T11:15:25Z","timestamp":1159182925000},"page":"503-507","source":"Crossref","is-referenced-by-count":16,"title":["Therapeutic options for the management of early neurotrophic keratopathy: A case report and review"],"prefix":"10.1016","volume":"77","author":[{"given":"Sherrol A.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan G.","family":"Kabat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.optm.2006.05.001_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00055735-199908000-00009","article-title":"Management of neurotrophic keratopathy","volume":"10","author":"Lambiase","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib2","first-page":"323","article-title":"The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course","volume":"LXXIII","author":"Alper","year":"1975","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.optm.2006.05.001_bib3","first-page":"100","article-title":"Neurotrophic Keratopathy","volume":"27","author":"Pushker","year":"2001","journal-title":"CLAO J"},{"key":"10.1016\/j.optm.2006.05.001_bib4","series-title":"Current ocular therapy","first-page":"506","article-title":"Neutroparalytic keratitis","author":"Mackie","year":"1995"},{"key":"10.1016\/j.optm.2006.05.001_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archopht.1954.00920050048005","article-title":"Mitotic and wound healing activities of the corneal epithelium: effect of sensory denervation","volume":"52","author":"Sigelman","year":"1954","journal-title":"Arch Ophthal"},{"key":"10.1016\/j.optm.2006.05.001_bib6","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1167\/iovs.03-0189","article-title":"Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy","volume":"44","author":"Negano","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.optm.2006.05.001_bib7","first-page":"1","article-title":"Mucus in the healthy and diseased eye","volume":"97","author":"Wright","year":"1977","journal-title":"Trans Ophthalmol Soc"},{"key":"10.1016\/j.optm.2006.05.001_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0002-9394(14)71169-9","article-title":"Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112","volume":"119","author":"Hosotani","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199903000-00002","article-title":"Classification of herpes simplex virus keratitis","volume":"18","author":"Holland","year":"1999","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2006.05.001_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0161-6420(85)34034-4","article-title":"Corneal complications from herpes zoster ophthalmicus","volume":"92","author":"Liesegang","year":"1985","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2006.05.001_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9394(77)90440-8","article-title":"Corneal sensation in Adie\u2019s syndrome","volume":"84","author":"Purcell","year":"1977","journal-title":"Am J Ophtalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0002-9394(14)72954-X","article-title":"Decrease in normal human corneal sensitivity with topical diclofenac sodium","volume":"118","author":"Szerenyi","year":"1994","journal-title":"Am J Ophthal"},{"key":"10.1016\/j.optm.2006.05.001_bib13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1001\/archopht.1977.04450120099012","article-title":"Neurotrophic corneal ulcers in diabetes mellitus","volume":"95","author":"Hyndiuk","year":"1977","journal-title":"Arch Ophthal"},{"key":"10.1016\/j.optm.2006.05.001_bib14","first-page":"318","article-title":"Effects of topical timolol (0.5%) and betaxolox (0.05%) on corneal sensitivity","volume":"61","author":"Weissman","year":"1984","journal-title":"Am J Optom Physiol Opt"},{"key":"10.1016\/j.optm.2006.05.001_bib15","series-title":"Principle and practice of ophthalmology","first-page":"140","article-title":"Viral Diseases of the cornea and external eye","author":"Pavan-Langston","year":"1994"},{"key":"10.1016\/j.optm.2006.05.001_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000117086","article-title":"Evaluation of fifth nerve dysfunction in 136 patients with middle and posterior cranial fossae","volume":"35","author":"Puca","year":"1995","journal-title":"Eur Neurol"},{"key":"10.1016\/j.optm.2006.05.001_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1367-0484(01)00002-9","article-title":"Risk factors for contact lens associated microbial keratitis","volume":"25","author":"Weissman","year":"2002","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.optm.2006.05.001_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2006.05.001_bib19","series-title":"Grayson\u2019s diseases of the cornea","first-page":"371","article-title":"Epithelial diseases","author":"Arff","year":"1977"},{"key":"10.1016\/j.optm.2006.05.001_bib20","first-page":"34","article-title":"Contemporary antibiotic and anti-inflammatory ocular drugs: a look at available anti-infective and anti-inflammatory ocular medications and how they work","volume":"20","author":"Dimartino","year":"2005","journal-title":"Contact Lens Spectrum"},{"key":"10.1016\/j.optm.2006.05.001_bib21","first-page":"2","article-title":"Neurotrophic keratitis requires decisive action","volume":"16","author":"Hannush","year":"2002","journal-title":"Eurotimes"},{"key":"10.1016\/j.optm.2006.05.001_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00003226-199707000-00009","article-title":"Topical anesthetic abuse ring keratitis: report of four cases","volume":"16","author":"Varga","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2006.05.001_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00003226-200005000-00003","article-title":"Tetracyclines and the treatment of corneal stromal ulceration: a review","volume":"19","author":"Ralph","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2006.05.001_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0161-6420(90)32587-3","article-title":"Tear film and ocular surface changes in a rabbit model of neurotrophic keratitis","volume":"97","author":"Gillard","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.optm.2006.05.001_bib25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bjo.2005.073114","article-title":"Treatment of neurotropic keratopathy with nasal dilator strips","volume":"89","author":"Magone","year":"2005","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00003226-199603000-00005","article-title":"Aqueous tear production in patients with neurotrophic keratitis","volume":"15","author":"Heigle","year":"1996","journal-title":"Cornea"},{"key":"10.1016\/j.optm.2006.05.001_bib27","first-page":"205","article-title":"Corneal melts associated with topically applied nonsteroidal anti-inflammatory drug","volume":"99","author":"Flach","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.optm.2006.05.001_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9394(14)70125-4","article-title":"Amniotic membrane transplantation for persistent epithelial defects with ulceration","volume":"123","author":"Lee","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.optm.2006.05.001_bib29","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1517\/14656566.5.10.2099","article-title":"Topical 0.05% cyclosporine in the treatment of dry eye","volume":"5","author":"Perry","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.optm.2006.05.001_bib30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2001-18663","article-title":"Autologous serum for otherwise therapy resistant corneal epithelial defect-prospective report on the first 70 eyes","volume":"218","author":"Ferreira de Souza","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.optm.2006.05.001_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004170050257","article-title":"Treatment of HSV-1 Stromal keratitis with topical cyclosporine A: a pilot study","volume":"237","author":"Heiligenhaus","year":"1999","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.3306916","article-title":"The nerve growth factor 35 years later","volume":"237","author":"Levi-Montalcini","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.optm.2006.05.001_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00165937","article-title":"Treatment of persistent epithelial defects in neurotrophic keratitis with epidermal growth factor: a preliminary open study","volume":"230","author":"Daniel","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.optm.2006.05.001_bib34","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(98)24024-4","article-title":"Treatment of neurotrophic keratopathy with substance-P derived peptide (FGLM) and insulin growth factor","volume":"35","author":"Chikama","year":"1998","journal-title":"Lancet"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183906003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183906003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T00:21:35Z","timestamp":1547338895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183906003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S1529183906003939"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2006.05.001","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}